Investor Type | Firm |
Type of Fund | Other |
Industries | IT (& TMT) • BioTech • Hardware (& Manufacturing) • Blockchain (& Cryptos) • Medical Devices (& Hospital Services) • DeepTech • Life Science |
Stages | Early,Seed |
Investing | United States |
Investment Range | $350,000 - $3,400,000 |
Excell Partners is a venture capital firm focused on bolstering the innovation economy in New York State by providing critical funding to startup companies. Established in 2005 and headquartered in Rochester, New York, Excell Partners operates with a mission to support seed and early-stage companies that demonstrate potential for growth and commercial success. As a pre-seed and seed fund, they target a broad spectrum of industries, investing in ventures operating in medical devices, materials, energy, biotechnology, agtech, imaging, information technology, software, and hardware manufacturing sectors, as well as emerging areas like blockchain and deep tech. Excell Partners is known for their disciplined investment process, which involves leveraging their maximum investment limit of $3,400,000 and minimum investment threshold of $350,000 to catalyze economic development within the state. The firm applies a methodical approach to investments, ensuring that the companies they finance have the capability to achieve significant milestones toward large scale commercialization and subsequent rounds of financing. Moreover, with a commitment to nurturing innovation and entrepreneurship, Excell Partners not only offers capital but also strategic guidance and networking opportunities to facilitate the growth trajectories of their portfolio companies. Their expertise spans across early stages of a company's life cycle, positioning them as an instrumental player in the transformation of cutting-edge ideas into market-ready solutions.